1. A virtual clinic increases anti‐TNF dose intensification success via a treat‐to‐target approach compared with standard outpatient care in Crohn's disease. Issue 12 (7th May 2020) Authors: Srinivasan, Ashish; van Langenberg, Daniel R.; Little, Robert D.; Sparrow, Miles P.; De Cruz, Peter; Ward, Mark G. Journal: Alimentary pharmacology & therapeutics Issue: Volume 51:Issue 12(2020) Page Start: 1342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-TNF Re-induction Is as Effective, Simpler, and Cheaper Compared With Dose Interval Shortening for Secondary Loss of Response in Crohn's Disease. (25th October 2017) Authors: Srinivasan, Ashish; Vasudevan, Abhinav; McFarlane, Anne; Sparrow, Miles P; Gibson, Peter R; Van Langenberg, Daniel R Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 3(2018:Mar.) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-TNF-associated immunogenicity: use a retroactive drug but a proactive approach. Issue 4 (17th July 2020) Authors: Srinivasan, Ashish; De Cruz, Peter; van Langenberg, Daniel R Journal: Gut Issue: Volume 70:Issue 4(2021) Page Start: 812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis. Issue 9 (17th May 2021) Authors: Hilley, Patrick; Gilmore, Robert; Srinivasan, Ashish; Choy, Matthew; De Cruz, Peter Journal: Inflammatory bowel diseases Issue: Volume 27:Issue 9(2021) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis. Issue 9 (19th August 2021) Authors: Hilley, Patrick; Gilmore, Robert; Srinivasan, Ashish; Choy, Matthew; De Cruz, Peter Journal: Inflammatory bowel diseases Issue: Volume 27:Issue 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Editorial: does anti‐TNF "treatment persistence" always equate to "effective treatment"? Only objective disease assessments can answer the question. Issue 5 (11th August 2021) Authors: Srinivasan, Ashish; van Langenberg, Daniel R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 54:Issue 5(2021) Page Start: 718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Editorial: outcomes following a second switch—evaluating clinical outcomes and patient perspectives in IBD. Issue 9 (8th April 2021) Authors: Srinivasan, Ashish; Haifer, Craig; Thin, Lena Journal: Alimentary pharmacology & therapeutics Issue: Volume 53:Issue 9(2021) Page Start: 1038 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Letter: choosing between ustekinumab and vedolizumab in anti‐TNF refractory Crohn's disease—the devil is in the detail. Issue 3 (13th July 2020) Authors: Srinivasan, Ashish; De Cruz, Peter; van Langenberg, Daniel R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 52:Issue 3(2020) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Letter: ustekinumab dose intensification for loss of response—should we re‐induce before shortening the dose interval?. Issue 3 (13th July 2020) Authors: Srinivasan, Ashish; De Cruz, Peter; van Langenberg, Daniel R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 52:Issue 3(2020) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease. Issue 6 (11th February 2021) Authors: Srinivasan, Ashish; van Langenberg, Daniel; De Cruz, Peter Journal: Inflammatory bowel diseases Issue: Volume 27:Issue 6(2021) Page Start: e69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗